MARKET CONTEXT: VOO $632.48 (+0.7% 7D, -0.7% 30D, RSI 58 — at SMA, stable) | QQQM $250.15 (-0.4% vs SMA, RSI 57) | VIXY $27.25 (RSI 45 — fear cooling from 62) | GLD $476.01 (RSI 64, +3.2% above SMA — breakout continues)
Market stabilizing. VIXY RSI 45 (down from 62 on 02-22) = fear subsiding. 18 entry zones active (5 extreme, 8 oversold, 5 approaching). ASAN sole GOLDEN signal (RSI 19 + $8.3M insider buying). WDAY RSI 29 is the last SaaS laggard. ISRG RSI 9 + insider selling = do NOT buy. SaaS bounce closed most Feb-22 entries (CRM 27->57, NOW 24->57). Data center power overbought (CEG RSI 82, EQIX RSI 87).
Entry Zones (IN ZONE NOW)
EXTREME OVERSOLD (RSI < 20) - Capitulation Territory
| Stock |
Current |
Zone |
RSI |
30D Chg |
Source |
Action |
Notes |
| ISRG |
$476.32 |
<$480 |
9 |
-19.7% |
biotech-scan, bargain-bin |
🔍 Research |
RETURNING. Surgical robotics monopoly. RSI 9 for 2nd scan. BUT insider selling -$282M at extreme low. Do NOT buy until insider selling stops. Data stale 02/05. |
| HIMS |
$15.23 |
<$16 |
9 |
-49.7% |
holdings, insider-scan |
🔍 Research |
RETURNING. RSI 9 extreme. -50% 30D. Insider selling -$186.5M. Falling knife, not dip. Fresh data 02/26. |
| LEGN |
$17.20 |
Avoid |
8 |
-27.1% |
biotech-scan |
❌ Don't Buy |
RETURNING. RSI <10 for 3rd consecutive scan. No reversal signal. Thesis broken. Data stale 02/09. |
| U |
$28.81 |
Avoid |
15 |
-37.2% |
insider-scan, holdings |
❌ Don't Buy |
RETURNING. -37% 30D, insiders selling -$282M into freefall. Data stale 02/02. |
| ORCL |
$152.95 |
$148-158 |
15 |
-20.4% |
ai-scan, bargain-bin |
✅ Strong Buy |
RETURNING. Oracle Cloud hyper-scaling. Database monopoly. -16% vs SMA. Data stale 02/03 — verify before acting. |
| IQV |
$162.31 |
$155-165 |
17 |
-32.2% |
biotech-scan |
🔍 Research |
NEW. IQVIA CRO/analytics leader. -32% 30D, -17% vs SMA. Pharma R&D spending cuts? Need thesis check. |
| SOFI |
$22.08 |
Avoid |
17 |
-24.6% |
insider-scan, holdings |
❌ Don't Buy |
RETURNING. Insiders selling -$651M at capitulation. Data stale 02/02. |
| NFLX |
$80.78 |
<$85 |
19 |
-11.7% |
bargain-bin, holdings |
⚠️ Caution |
RETURNING. 300M+ subs. Ad tier growth. BUT insiders selling -$1.3B at RSI 19. Data stale 02/03. |
| ASAN |
$9.91 |
$9-10 |
19 |
-23.1% |
insider-scan, holdings |
🏆 Golden Signal |
RETURNING. RSI 19 + $8.3M insider BUYING = sole golden signal in universe. 3rd consecutive scan. Data stale 02/02. |
OVERSOLD (RSI 20-30) - Strong Entry Zone
| Stock |
Current |
Zone |
RSI |
30D Chg |
Source |
Action |
Notes |
| PINS |
$22.00 |
$20-23 |
20 |
-17.0% |
insider-scan, holdings |
🔍 Watch |
RETURNING. Social media pressure. Insider selling -$116M. Data stale 02/02. |
| ZS |
$169.39 |
<$172 |
23 |
-23.7% |
bargain-bin, cloud-etfs |
⚠️ Caution |
RETURNING. Zero-trust cloud. Insiders selling -$174M into dip. Data stale 02/05. DCA only. |
| AFRM |
$61.99 |
$58-64 |
24 |
-23.3% |
insider-scan, holdings |
🔍 Watch |
RETURNING. BNPL leader. Insiders selling -$327M. Data stale 02/02. |
| SAP |
$196.98 |
<$202 |
25 |
-18.1% |
bargain-bin |
📈 Accumulate |
RETURNING. Global ERP king. 400K customers. Cloud migration. No insider exit flags. Data stale 02/03. |
| OKTA |
$81.64 |
$79-84 |
28 |
-6.9% |
bargain-bin |
🔍 Watch |
RETURNING. Identity management. Breach recovery. Needs catalyst. Data stale 02/03. |
| GOOGL |
$306.33 |
$300-310 |
29 |
-8.1% |
ai-scan, bargain-bin, holdings |
📈 Accumulate |
RETURNING. Search/cloud monopoly. Re-entered oversold (was RSI 32 on 02/22, now 29). BUT insider selling -$294M. Fresh data 02/26. |
| UNH |
$293.19 |
<$298 |
29 |
-12.5% |
bargain-bin |
🔍 Watch |
RETURNING. Largest US health insurer. Regulatory/political risk elevated. Data 02/13. |
| WDAY |
$138.57 |
$134-142 |
29 |
-27.4% |
cloud-etfs, bargain-bin, candidates |
✅ Strong Buy |
RETURNING. Last SaaS laggard still oversold. Enterprise HR lock-in. -27% 30D while CRM recovered to RSI 57. Fresh data 02/26. |
APPROACHING OVERSOLD (RSI 30-40) - Watch Closely
| Stock |
Current |
Zone |
RSI |
30D Chg |
Source |
Action |
Notes |
| ADBE |
$269.39 |
$263-272 |
30 |
-19.8% |
bargain-bin, cloud-saas |
📈 Accumulate |
RETURNING. Creative cloud monopoly. Firefly AI. -10.2% vs SMA. Data stale 02/05. Right at 30 threshold. |
| GIS |
$44.85 |
$43-46 |
30 |
+0.5% |
defensive-scan, consumer-staples |
📈 Accumulate |
NEW. Only staple NOT in overbought rotation. -3.6% vs SMA. Contrarian setup. Fresh data 02/26. |
| PANW |
$166.95 |
$162-170 |
33 |
-12.6% |
bargain-bin |
🔍 Watch |
RETURNING. Zero-trust leader. Insiders selling -$1.8B tempers conviction. Data 02/13. |
| AMZN |
$206.73 |
$200-212 |
34 |
-13.3% |
ai-scan, bargain-bin, holdings |
📈 Accumulate |
RETURNING. AWS + e-commerce monopoly. RSI improved 25->34. CAVEAT: Bezos -$10.9B selling. Fresh data 02/26. |
| INTU |
$389.33 |
$378-395 |
35 |
-30.7% |
cloud-etfs, bargain-bin |
📈 Accumulate |
RETURNING. Bounced from RSI 18 extreme. TurboTax monopoly. Tax season tailwind. Fresh data 02/26. |
| TMO |
$515.03 |
$505-520 |
32 |
-17.8% |
bargain-bin, holdings |
📈 Accumulate |
RETURNING. Life sciences monopoly. Recovered from RSI 19. GLP-1 tailwind. Insider selling -$320M. Fresh data 02/26. |
| FSLR |
$201.52 |
$190-208 |
35 |
-17.1% |
energy |
📈 Accumulate |
NEW. Domestic solar leader. -11.8% vs SMA. IRA/tariff protected. Fresh data 02/26. |
| LOW |
$264.70 |
$258-268 |
41 |
-4.8% |
retail-scan |
🔍 Watch |
NEW. Home improvement leader. RSI dropped from 66 to 41 in 4 days. -4.3% vs SMA. Fresh data 02/26. |
| MDT |
$98.61 |
$94-97 |
36 |
-2.0% |
biotech-scan |
🔍 Watch |
NEW. Medical devices. RSI approaching oversold. Data 02/23. |
Price Alerts (Waiting for Entry)
| Stock |
Alert |
Entry Zone |
Source |
Set Date |
Status |
| AMD |
$185-195, RSI <48 |
-19% 30D laggard, thesis intact |
nvda-ecosystem |
2026-02-22 |
⏳ Waiting — RSI 57, above zone |
| TSLA |
$380-415, RSI <30 |
Insider buying +$200.6M |
insider-scan |
2026-02-22 |
⏳ Waiting — RSI 56 |
| ARM |
$110-115, RSI <55 |
Wait for full reset from RSI 71 |
nvda-ecosystem |
2026-02-16 |
⏳ Waiting — RSI 71, still extended |
| TSM |
$345-358, RSI <60 |
SMA retest after +12% run |
nvda-ecosystem |
2026-02-16 |
⏳ Waiting — RSI 71, still extended |
| NVDA |
$181-186, RSI <55 |
SMA retest, core AI position |
nvda-ecosystem |
2026-02-22 |
⏳ Watching — RSI 63, above zone |
| AVGO |
$295-305, RSI <45 |
Custom silicon pullback |
nvda-ecosystem |
2026-02-26 |
⏳ Waiting — RSI 51, watch for deeper dip |
| CEG |
$265-285, RSI reset to 55 |
Nuclear AI power thesis |
energy, ai-infra |
2026-02-26 |
⏳ Waiting — RSI 82, overbought now |
| GEV |
$750-800, RSI reset to 60 |
Grid infrastructure |
energy, ai-infra |
2026-02-26 |
⏳ Waiting — RSI 77, extended |
| CSCO |
$72-76, RSI <45 |
Post-earnings contrarian |
ai-infra |
2026-02-26 |
⏳ Watching — RSI 50, not yet oversold |
| SCHD/VYM |
After RSI reset <60 |
Dividend ETFs at RSI 87-90 |
etf-universe |
2026-02-26 |
⏳ Waiting — extreme overbought, do NOT chase |
Exit Alerts (Holdings)
| Stock |
Alert |
Type |
Entry |
Current |
P&L |
Set Date |
Status |
| BE |
$140 |
Stop-loss (-15%) |
$164.96 |
$163.68 |
-0.8% |
2026-02-03 |
🟡 Near entry, above stop — recovered from 02/22 scare |
| WMT |
$109 |
Stop-loss (-15%) |
$128.08 |
$124.73 |
-2.6% |
2026-02-03 |
🟡 Below entry, well above stop |
| NET |
$151 |
Stop-loss (-15%) |
$178.30 avg |
$173.33 |
-2.8% |
2026-01-26 |
🟡 Below entry — -10% 7D pullback, monitor closely |
| DOCN |
Watch |
Sudden crash |
— |
$53.82 |
+14% est |
2026-02-26 |
🚨 NEW — -21% 7D crash. Was compounder, now falling. Check earnings/catalyst. |
| MRNA |
RSI 87 |
Sell into strength |
— |
$51.72 |
+24% 7D |
— |
🚨 Trim — RSI 87 extreme overbought. Swan watch position. |
| PHGE |
RSI 77 |
Sell into strength |
— |
$6.23 |
+176% 30D |
— |
🚨 Sell — Parabolic. RSI 77. Stale data 02/02. |
| NTLA |
RSI 73 |
Watch for fade |
— |
$13.67 |
— |
— |
⚠️ Watch — Surging without clear catalyst. Biotech fades fast. |
| BTC ETF |
$34 |
Stop-loss (-15%) |
$40.05 |
— |
— |
2026-02-03 |
⏳ Active — need price check |
| ARKX |
$28 |
Stop-loss (-15%) |
$32.40 |
— |
— |
2026-02-03 |
⏳ Active — need price check |
Sector Rotation Signals
| Signal |
Trigger |
What It Means |
Status |
| Gold breakout accelerating |
GLD RSI 64, +6.2% 7D, +3.2% above SMA |
Safe-haven bid still strong. Institutions buying safety alongside equity bounce. |
🟢 ACTIVE — Hold GLD |
| VIXY cooling |
RSI 45 (was 62 on 02/22) |
Fear subsiding from Feb highs. Closer to all-clear. |
🟢 Improving — Watch for RSI <40 |
| Dividend ETFs extreme overbought |
SCHD RSI 90, VYM RSI 87 |
Institutions hiding in dividends. Defensive rotation overdone. Do NOT chase. |
🔴 Danger — Trim/avoid SCHD/VYM |
| SaaS bounce from capitulation |
CRM RSI 27->57, NOW RSI 24->57 in 4 days |
Most SaaS entry window closed. WDAY (RSI 29) last opportunity. |
🟡 Window closing |
| Data center power overbought |
CEG RSI 82, EQIX RSI 87, GEV RSI 77 |
Nuclear/power theme priced in. Pullback risk elevated. |
🔴 Overbought — Don't chase |
| Cloud ETFs bounced to neutral |
WCLD RSI 53, IGV RSI 54 (was 32-33) |
Relief rally, not confirmed recovery. Need SMA reclaim. |
🟡 Watch for SMA reclaim |
| GDX lagging GLD |
GLD +6.2% 7D vs GDX -15.4% 7D |
Unusual divergence — gold miners NOT confirming gold rally. |
🟡 Watch — GDX catch-up or GLD reversal? |
| Home improvement weakening |
LOW RSI 66->41 in 4 days |
Housing data weakness hitting HD/LOW. Potential entry forming. |
🟡 Emerging entry |
Insider Activity Summary
| Signal |
Stocks |
Implication |
| 🏆 GOLDEN |
ASAN (RSI 19 + $8.3M buying) |
Sole golden signal for 3rd consecutive scan. Multiple insiders buying at capitulation. Highest conviction entry. |
| 🟢 BUYING |
TSLA (+$200.6M, RSI 56), CRSP (+$26.6M, RSI 81) |
TSLA at neutral RSI — not oversold; CRSP buying at overbought = insiders confident in gene editing thesis |
| 🔴 EXTREME SELL INTO DIP |
ISRG (-$282M, RSI 9), HIMS (-$187M, RSI 9), U (-$282M, RSI 15), SOFI (-$651M, RSI 17) |
Insiders abandoning during extreme capitulation. These are NOT buy signals despite low RSI. |
| ⚠️ SELLING INTO DIP |
NFLX (-$1.3B, RSI 19), AFRM (-$327M, RSI 24), GOOGL (-$294M, RSI 29), ZS (-$174M, RSI 23), PINS (-$116M, RSI 20) |
Smart money exiting oversold positions. Tempers buy conviction. |
| 🔍 HEAVY SELLING AT NEUTRAL |
AMZN (-$10.9B, Bezos estate), PLTR (-$3.4B), NVDA (-$3B), LLY (-$4.8B), PANW (-$1.8B), SNOW (-$1.2B) |
Institutional distribution at fair-value levels. Routine for most. |
Pending Research Actions
| Action |
Source |
Priority |
Status |
| Execute ASAN position (RSI 19, $8.3M insider buying, 3rd scan golden signal) |
insider-scan, holdings |
CRITICAL |
🔍 Todo |
| Execute WDAY entry (RSI 29, last SaaS laggard, -27% 30D, enterprise HR moat) |
cloud-etfs, bargain-bin |
HIGH |
🔍 Todo |
| Research DOCN -21% crash (was compounder, sudden drop — earnings or structural?) |
holdings |
HIGH |
🔍 Todo |
| Trim MRNA (RSI 87, extreme overbought — take profit on swan watch position) |
holdings, biotech |
HIGH |
🔍 Todo |
| Trim/Sell PHGE (RSI 77, +176% 30D parabolic — sell into strength) |
holdings |
HIGH |
🔍 Todo |
| Research IQV entry (RSI 17, NEW — CRO leader -32% 30D, need thesis check) |
biotech-scan |
HIGH |
🔍 Todo |
| Decide U position (RSI 15, -37% 30D, insiders selling — cut or hold?) |
holdings |
HIGH |
🔍 Todo — carry forward |
| Review HIMS (RSI 9, -50% 30D, insiders selling — exit or speculative hold?) |
holdings |
HIGH |
🔍 Todo — carry forward |
| ADBE entry evaluation (RSI 30, -20% 30D, creative cloud monopoly) |
bargain-bin, cloud-saas |
MEDIUM |
🔍 Todo |
| GOOGL DCA decision (RSI 29, re-entered oversold, but -$294M insider selling) |
ai-scan, holdings |
MEDIUM |
🔍 Todo |
| Research FSLR (RSI 35, -17% 30D — solar policy risk vs tariff protection) |
energy |
MEDIUM |
🔍 Todo |
| INTU accumulation (RSI 35, -31% 30D, tax season structural tailwind) |
cloud-etfs |
MEDIUM |
🔍 Todo |
| Monitor NET stop-loss ($151 stop, currently $173 — -10% 7D pullback concerning) |
holdings |
MEDIUM |
⏳ Watching |
| Monitor VIXY (RSI 45, cooling — all-clear at RSI <40) |
etf-universe |
MEDIUM |
⏳ Watching |
| Research NVO collapse (-22.7% 7D, -41.5% 30D — GLP-1 thesis cracking?) |
biotech-scan |
LOW |
🔍 Todo |
| Fetch missing data (DXCM, RGEN, DG, DLTR, FIVE, AMAT) |
various scans |
LOW |
🔍 Todo |
| Research GIS contrarian (RSI 30, only staple not in overbought rotation) |
defensive-scan |
LOW |
🔍 Todo |
The Gold
Key Discoveries
| Discovery |
Implication |
| VIXY RSI 45 (was 62 on 02-22) — fear subsiding |
Market risk appetite improving. Closer to all-clear for adding risk. But not there yet — wait for RSI <40. |
| SaaS bounce closed most Feb-22 entries in 4 days |
CRM 27->57, NOW 24->57, META 26->44 — the oversold window was brief. WDAY (RSI 29) is the last one open. Act now or miss it. |
| ASAN golden signal for 3rd consecutive scan |
Persistence of insider buying at capitulation = floor forming. Highest conviction entry in the universe. |
| DOCN -21% 7D surprise crash |
Was a compounder (+14% gain), now at risk. Need to identify catalyst before deciding hold/sell. |
| ISRG RSI 9 + insider selling -$282M |
Despite monopoly quality, insiders are exiting at all-time RSI extreme. Do NOT buy until insider selling stops. |
| NVO -22.7% 7D, -41.5% 30D |
GLP-1 competitive disruption is real and accelerating. Biggest single-stock collapse in scan universe. Avoid. |
| IQV RSI 17, -32% 30D — new extreme entry candidate |
CRO/health analytics leader in capitulation. Need to understand if pharma R&D cuts are cyclical or structural. |
| SCHD RSI 90, VYM RSI 87 |
Dividend ETFs in extreme overbought = institutions still hiding in safety. When this unwinds, growth names re-rate. |
| GEV +29.6% 30D at RSI 77 |
Data center power demand is the biggest infrastructure trade of this cycle — but you've missed the entry. Wait for reset. |
| WDAY RSI 29 while CRM recovered to RSI 57 |
WDAY is the only cloud name that did NOT participate in the SaaS bounce. Either structural issue or last bargain. |
Mistakes (Don't Repeat)
| Mistake |
Lesson |
| Hesitating on CRM at RSI 27 (02-22) |
CRM went 27->57 in 4 days. RSI <30 in quality names = act fast, windows close violently. |
| No DOCN stop-loss on a compounder |
Even winners need stop-losses. DOCN -21% 7D proves it. Set stops on ALL positions. |
| Treating ISRG RSI 9 as buy signal without checking insiders |
Low RSI alone is NOT a buy signal. Always cross-check insider data. -$282M selling = insiders see more pain. |
| Missing LOW RSI 66->41 collapse in 4 days |
Fast RSI drops in quality names = opportunity forming. Need daily monitoring not weekly. |
Open Questions
- WDAY RSI 29 while CRM bounced to 57 — is WDAY a structural loser or the best remaining SaaS entry?
- ASAN golden signal 3rd scan — when does thesis convert to position? What is the specific catalyst?
- DOCN -21% 7D — earnings miss, guidance cut, or competitive pressure?
- IQV -32% 30D — is pharma R&D spending cut cyclical (buy) or AI-structural (avoid)?
- NVO -41.5% 30D — is this GLP-1 competitive disruption permanent or an overreaction?
- VIXY RSI 45 — will it break below 40 for clean all-clear, or does macro headwind persist?
- SCHD/VYM RSI 87-90 — when does defensive rotation reverse back to growth?
Sources: 13 sector scans, 1 holdings file, 11 candidate files, 1 portfolio snapshot. Validated via OHLC data 2026-02-26. Previous actions: 2026-02-22-actions.md.
Sources
- Tape data (price/RSI/trend figures): desk pre-computed watchlist summaries as of the artifact date — *.